Skip to main content
Clinical Trials/NCT02834117
NCT02834117
Completed
Phase 4

Comparison of the Number of Visits and the Quality of Life Versus Natural Cycle in Stimulated Cycle Before Frozen Embryo Transfer

Dr Massin Nathalie1 site in 1 country124 target enrollmentMay 2015

Overview

Phase
Phase 4
Intervention
natural cycle
Conditions
Fertility
Sponsor
Dr Massin Nathalie
Enrollment
124
Locations
1
Primary Endpoint
Number of visits
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Embryo freezing is a technique used regularly to optimize the pregnancy rate in case of infertility. This method is performed in presence of supernumerary embryo(s) after fresh transfer, or after freeze all embryos in case of medical reasons. It is necessary to control that the transfer is performed when the endometrium is receptive, which is essential for embryo implantation and pregnancy. This period is defined as the "implantation window". Endometrial preparation can be achieved by hormone replacement therapy (HRT) or moderate ovarian stimulation (SO). The implantation window can also be assessed by monitoring of a natural cycle (NC). The objectives of this open randomized study is to compare the number of visits (ultrasound and blood tests) induced by the SO or NC as well as the women quality of life in both groups.

Detailed Description

For infertile couples supported by in vitro fertilization, embryo freezing is a technique used regularly to optimize the pregnancy rate per retrieval of oocytes. This method is performed in case of supernumerary embryo(s) after fresh embryo transfer, or freeze all of the embryonic cohort in case of medical reasons preventing the transfer. The embryo or embryos can then be thawed and transferred (FET) to achieve a live birth. However, it is necessary to first ensure that the transfer is carried out at a time when the endometrium is receptive, which is essential for embryo implantation and pregnancy. This period is defined as the "implantation window". Endometrial preparation can be performed by hormone replacement therapy (HRT) or moderate ovarian stimulation (SO). The implantation window can also be assessed by the monitoring of a natural cycle (NC). The choice of the key moment for the transfer is determined by ovulation and / or the rise of progesterone. To date, no study has demonstrated the superiority of one protocol over another in terms of birth rates. In the investigative center, treatment is usually carried out by daily subcutaneous injections of gonadotrophins followed by ovulation induction. In this context, the implementation of the FET in natural cycle may appear less burdensome for the patient and more physiological. The consideration is additional constraints, NC imposing more frequent monitoring (ultrasound and / or hormone assays) to detect the ovulation peak and less freedom in choosing the date of transfer. The average number of visits with SO is 2.6 per cycle. The aim of this study is to compare the stresses and safety of these two therapeutic proposals to determine the least restrictive for patients.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
March 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Dr Massin Nathalie
Responsible Party
Sponsor Investigator
Principal Investigator

Dr Massin Nathalie

Dr

Centre Hospitalier Intercommunal Creteil

Eligibility Criteria

Inclusion Criteria

  • Affiliation to the general social security regime and benefiting from 100% infertility;
  • Regular Cycles 26 to 35 days;
  • Support in IVF or ICSI ;
  • Existence of at least 2 frozen embryos to J2 or J3;
  • Treated for their first or second cycle of TEC.

Exclusion Criteria

  • Donor sperm;
  • Irregular cycles and / or polycystic ovary syndrome;
  • Embryos frozen at J1 or J5 / J6 or double planned transfer or transfer of 3 embryos intended;
  • Patients who have had more than 3 transfers or more than 6 embryos replaced without pregnancy or puncture rank\> 3;
  • uterine malformation existing;
  • Presence of a hydrosalpinx.

Arms & Interventions

Natural cycle

Ovulation is not induced by drugs

Intervention: natural cycle

Moderate ovarian stimulation

Ovulation is induced by recombinant follitropin alpha and recombinant choriogonadotropin

Intervention: moderate ovarian stimulation

Outcomes

Primary Outcomes

Number of visits

Time Frame: From inclusion visit to embryo transfer : up to 90 days

number of visits (for clinical examination, ultrasound and hormonal dosage) required to monitor ovulation in both groups

Secondary Outcomes

  • Fertiqol(From inclusion visit to embryo transfer : up to 90 days)
  • defrost cancellation rate(From inclusion visit to embryo transfer : up to 90 days)
  • transfer on weekends and holidays(From inclusion visit to embryo transfer : up to 90 days)
  • HCG levels> 100 U / L(From inclusion visit to pregnancy test : up to 100 days)
  • pregnancy(From pregnancy test to ultrasound at 6 week of gestation : up to 100 days)
  • Birth(From transfer to delivery : up to 9 months)
  • Gestationnal age at delivery(From transfer to delivery : up to 9 months)
  • Implantation(From transfer to delivery : up to 9 months)
  • Miscarriage(From pregnancy test to ultrasound at 6 week of gestation : up to 100 days)
  • Cost(From pregnancy test to ultrasound at 6 week of gestation : up to 100 days)

Study Sites (1)

Loading locations...

Similar Trials